Benjamin Zhiyi Chen

Chief Executive Officer (Interim) / President at Mangrove Therapeutics.

Raised on Mangrove Therapeutics filings

$2.5M

of $5M offered across 1 Form D filing

Company

Biotech · Sacramento, CA

Therapies targeting an RNA regulator of inflammation

Therapies targeting an RNA regulator of inflammation

Mangrove Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 31, 2026	Other	$2.5M/ $5M	Form D

Also named on Mangrove Therapeutics filings